128 related articles for article (PubMed ID: 8790559)
1. Alterations of the RB tumour suppressor gene in hepatocellular carcinoma and hepatoblastoma cell lines in association with abnormal p53 expression.
Farshid M; Hsia CC; Tabor E
J Viral Hepat; 1994; 1(1):45-53. PubMed ID: 8790559
[TBL] [Abstract][Full Text] [Related]
2. Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma.
Lin Y; Shi CY; Li B; Soo BH; Mohammed-Ali S; Wee A; Oon CJ; Mack PO; Chan SH
Ann Acad Med Singap; 1996 Jan; 25(1):22-30. PubMed ID: 8779541
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the tumor suppressor genes p53, RB, p16/MTS1, and p15/MTS2 in human pancreatic cancer and hepatoma cell lines.
Kaino M
J Gastroenterol; 1997 Feb; 32(1):40-6. PubMed ID: 9058294
[TBL] [Abstract][Full Text] [Related]
4. Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines.
Puisieux A; Galvin K; Troalen F; Bressac B; Marcais C; Galun E; Ponchel F; Yakicier C; Ji J; Ozturk M
FASEB J; 1993 Nov; 7(14):1407-13. PubMed ID: 8224613
[TBL] [Abstract][Full Text] [Related]
5. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
Murakami Y; Hayashi K; Hirohashi S; Sekiya T
Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254
[TBL] [Abstract][Full Text] [Related]
6. Absence of p53 gene mutation and infrequent overexpression of p53 protein in hepatoblastoma.
Chen TC; Hsieh LL; Kuo TT
J Pathol; 1995 Jul; 176(3):243-7. PubMed ID: 7674087
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines.
Hosono S; Lee CS; Chou MJ; Yang CS; Shih CH
Oncogene; 1991 Feb; 6(2):237-43. PubMed ID: 1847999
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
[TBL] [Abstract][Full Text] [Related]
9. Infrequent mutations of the TP53 gene and no amplification of the MDM2 gene in hepatoblastomas.
Ohnishi H; Kawamura M; Hanada R; Kaneko Y; Tsunoda Y; Hongo T; Bessho F; Yokomori K; Hayashi Y
Genes Chromosomes Cancer; 1996 Mar; 15(3):187-90. PubMed ID: 8721685
[TBL] [Abstract][Full Text] [Related]
10. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
11. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes.
Ruggeri B; Zhang SY; Caamano J; DiRado M; Flynn SD; Klein-Szanto AJ
Oncogene; 1992 Aug; 7(8):1503-11. PubMed ID: 1630814
[TBL] [Abstract][Full Text] [Related]
12. Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method.
Kashii T; Mizushima Y; Monno S; Nakagawa K; Kobayashi M
J Cancer Res Clin Oncol; 1994; 120(3):143-8. PubMed ID: 8263009
[TBL] [Abstract][Full Text] [Related]
13. [The expression of tumor suppressor gene p53 and Rb gene in nasopharyngeal carcinoma].
Song Y; Wang L; Huang G; Huang R; Yuan S; Liu Y
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Sep; 28(3):268-71. PubMed ID: 10684031
[TBL] [Abstract][Full Text] [Related]
14. Tissue microarray immunohistochemical profiles of p53 and pRB in hepatocellular carcinoma and hepatoblastoma.
Azlin AH; Looi LM; Cheah PL
Asian Pac J Cancer Prev; 2014; 15(9):3959-63. PubMed ID: 24935581
[TBL] [Abstract][Full Text] [Related]
15. Lack of p53 point mutations in chemically induced mouse hepatoblastomas: an end-stage, highly malignant hepatocellular tumor.
Calvert RJ; Tashiro Y; Buzard GS; Diwan BA; Weghorst CM
Cancer Lett; 1995 Aug; 95(1-2):175-80. PubMed ID: 7656227
[TBL] [Abstract][Full Text] [Related]
16. A new mutational hot-spot in the p53 gene in human hepatocellular carcinoma.
Diamantis ID; McGandy C; Chen TJ; Liaw YF; Gudat F; Bianchi L
J Hepatol; 1994 Apr; 20(4):553-6. PubMed ID: 8051396
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain.
Challen C; Lunec J; Warren W; Collier J; Bassendine MF
Hepatology; 1992 Dec; 16(6):1362-6. PubMed ID: 1332921
[TBL] [Abstract][Full Text] [Related]
18. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of the p16-Rb pathway in Korean hepatocellular carcinomas.
Lee TJ; Bae JJ; Lee JS; Lee SY; Kim HJ; Kim SK; Lee JY; Lee TY
Hepatogastroenterology; 2000; 47(36):1663-8. PubMed ID: 11149028
[TBL] [Abstract][Full Text] [Related]
20. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
